for the Myocardial Infarction Data Acquisition System (MIDAS14) Study Group Background-We assessed trends in the prognosis of patients with acute myocardial infarction hospitalized in New Jersey hospitals. In recent decades, in-hospital mortality has declined markedly but the decline in longer-term mortality is less pronounced, implying that mortality after discharge has worsened. Methods and Results-Using the Myocardial Infarction Data Acquisition System (MIDAS), we examined the outcomes of 285 397 patients hospitalized for a first acute myocardial infarction between 1986 and 2007. Mortality at discharge decreased by 9.4% from 16.9% to 7.5% (annual change, Ϫ0.44; 95% confidence interval, Ϫ0.49 to Ϫ0.40), but the decrease at 1 year was less pronounced (6.4%) because of an increase in mortality from discharge to 1 year after discharge (from 12.1% to 13.9%; annual change, ϩ0.15; 95% confidence interval, ϩ0.10 to ϩ0.20). Mortality from 30 days after discharge to 1 year, a measure not affected by length of stay, increased by 1.2% (annual change, ϩ0.10; 95% confidence interval, ϩ0.06 to ϩ0.23). The effect was more evident in the older age groups and was due to noncardiovascular mortality, especially from respiratory and renal diseases, septicemia, and cancer. All effects remained statistically significant (PϽ0.0001) after adjustment for demographics, comorbidities, infarction type, complications, and interventions. Piecewise linear regressions confirmed these trends. Conclusions-Postdischarge mortality of patients with acute myocardial infarction is increasing, primarily because of higher noncardiovascular mortality in the older age groups. (Circ Cardiovasc Qual Outcomes. 2010;3:581-589.)
I n recent decades, a marked decrease of in-hospital mortality of patients with acute myocardial infarction (AMI) has been documented in clinical trials, in prospective registries, and in epidemiological studies. [1] [2] [3] [4] [5] Although longer-term mortality of AMI has also declined, in some studies this decline is less pronounced than mortality at discharge, implying that mortality after discharge has worsened. 1,4,6 -9 In recent years, AMI patients are older and have more comorbidities, the length of hospital stay has decreased, the diagnostic criteria have changed, and better control of risk factors may have resulted in smaller AMIs. 4 -6,9 -12 Many improvements have been made in the management of AMI and in secondary prevention with reperfusion, medications, revascularization, and emphasis on process improvement. 1, 3, 4, 6, 7, [13] [14] [15] [16] [17] [18] 
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The purpose of the present study was to examine mortality trends observed among AMI patients admitted to New Jersey hospitals while considering changes in patient characteristics, comorbidities, complications, interventions, and length of stay.
Methods

Data Sources
The data for this study were obtained from the Myocardial Infarction Data Acquisition System (MIDAS) from January 1, 1986, to December 31, 2008. 19, 20 Cases admitted in December and discharged in January were assigned to the year of discharge. MIDAS contains hospital discharge data from nonfederal acute care hospitals in New Jersey and includes all records with a primary diagnosis of AMI (International Classification of Disease 9th Revision, 410.0 to 410. 9 [ICD9]).
Out-of-hospital death information (date and cause of death) was obtained by matching the MIDAS records to the New Jersey death registration files, using a public automated record linkage and consolidation software (The Link King). 21 In a study of 500 000 cases with a blinded clerical review of a sample of 500 record pairs, the algorithm had a sensitivity of 96.7% and a positive predictive value of 96.1%. 22 First AMIs were AMIs occurring for the first time in an individual during the duration of the study and without the diagnosis of prior or old AMI among the discharge diagnoses. To obtain an estimate of deaths occurring outside the state of New Jersey, 7308 randomly selected MIDAS from the years 1986 to 2004 cases were matched to the National Death Index. Only 14 deaths (0.19% of the sample) occurred out-of-state within 30 days of discharge and 119 within 1 year of discharge representing or 0.01% and 0.04%, respectively, of the patients admitted. Deaths occurring in hospice or home hospice (nϭ540) were included in the in-hospital deaths.
WHAT IS KNOWN
• A marked decrease of in-hospital mortality of acute myocardial infarction (AMI) patients has occurred in recent decades. • Longer-term mortality of AMI has also declined, but in some studies this decline is less pronounced than mortality at discharge. • Many changes in the characteristics and management of AMI have occurred during the same decades.
WHAT THE STUDY ADDS
• Studying 285 397 patients hospitalized in New Jersey for a first AMI between 1986 and 2007, we observed an increase in mortality after discharge. • The increase in postdischarge mortality was more evident in the older age groups and was due to noncardiovascular mortality, especially respiratory and renal diseases, septicemia, and cancer.
The study included 285 397 patients ages 35 years or older who were discharged from New Jersey hospitals with a first AMI as the primary reason for admission between 1986 and 2007. AMI patients admitted to nursing homes or to federal hospitals (amounting to Ͻ3% of all AMI patients) were excluded. Patients with an AMI listed as a secondary diagnosis (ie, not the reason for admission) were also excluded (nϭ88 905). The New Jersey State Institutional Review Board and the University of Medicine and Dentistry of New Jersey Institutional Review Board approved the study.
Study Variables
In-hospital mortality was calculated as the ratio of the number of patients who died during the AMI admission divided by the number of AMI patients admitted. One-year mortality was calculated as the ratio of the number of patients who died within 1 year from the date of admission divided by the number of AMI patients admitted. Thirty-day and 1-year postdischarge mortality was computed as the ratio of the number of patients who died between discharge and 30 days (or 1 year) after discharge divided by the total number of those discharged alive. Interval after discharge mortality between 30 days and 1 year after discharge was calculated as the ratio of the number of patients who died between 31 days and 1 year after discharge divided by the number of patients who were discharged alive. All-cause, cardiovascular disease (CVD), and non-CVD (NCVD) death after discharge mortality was calculated. The difference of the mortality in 1986 and the mortality at each subsequent year of the study was calculated. CVD death included codes ICD9 390 to 459, ICD10 I00-I99. NCVD death included all other causes of death.
Covariates included patient demographics, AMI site, comorbidities, and the use of invasive procedures during the admission. AMI site was coded at discharge as follows: transmural (anterior ICD9 410.0, 410. 23 Information on insurance (commercial, Medicare, Medicaid, HMO, and self-pay) was available only for patients discharged from 1994 onward.
Statistical Analysis
Statistical analyses were performed using SAS v.9.2 software. Patient demographic and clinical characteristics were compared across hospitalization years using the Cochran-Armitage test or Mantel-extension 2 test for categorical variables and ANOVA F tests for continuous variables. A series of general linear models were generated to calculate the average annual change of mortalities and corresponding 95% confidence intervals (CI). Goodness-of-fit of the linear regression was evaluated by R 2 and probability value for F test statistic. We also investigated a possible nonlinear association between mortality and index hospitalization year using piecewise linear fits by hospitalization year (1986 to 1992, 1993 to 2001, and 2002 to 2007) . Multivariate logistic regression was used to measure the effect of calendar year on in-hospital and 30-day mortality end points with the referent year of 1986, as well as with the calendar year as a continuous variable, after adjusting for patient age, sex, race, AMI site, comorbidities, complications, and invasive cardiac procedures performed during the admission. One-year mortality end points were analyzed using Cox regression adjusting for the variables listed above.
Sensitivity analysis was performed using the subset of patients admitted between 1994 and 2007. In this group (nϭ185 483), we examined trends adjusting for insurance type in addition to the variables used in the primary analysis. Regression lines were fitted to examine trends of all cause, CVD, and NCVD mortality from admission as well as after discharge and starting from 30 days after discharge.
Results
Trends in Patient Characteristics
During the years of the study, the age of the patients with first AMI increased by 1.9 years (Table A of the online-only Data Supplement). The percentage with commercial insurance decreased by 4.9%, whereas HMO increased by 11.3%. The percentage of patients with subendocardial AMI increased by 46.2%, from 16.6% to 62.8%, with hypertension increased by 25.0%, with anemia by 5.4%, with chronic obstructive pulmonary disease by 4.1%, with chronic renal disease by 14.4%, with diabetes by 4.4%, and with cancer by 1.5%. The percentage of patients who had percutaneous coronary intervention during the index hospitalization increased 26-fold, from 1.3% to 34.1%, whereas the length of stay decreased by half from 11.3 to 5.7 (PϽ0.0001 for all changes above).
In-Hospital and Postdischarge Mortality
From 1986 to 2007, in-hospital mortality decreased by 9.4% from 16.9% to 7.5% (annual change, Ϫ0.44; 95% CI, Ϫ0.49 to Ϫ0.40; R 2 ϭ0.95; Table 1 and Figure 1 ). Mortality from admission to 30 days also decreased by 8.0%, from 18.2% to 10.2% (annual change, Ϫ0.36; 95% CI, Ϫ0.41 to Ϫ0.31; R 2 ϭ0.91), as did mortality from admission to 1 year (by 6.4% Table B and Figure 2 ). In-hospital and 30-day mortality decreased in all 3 time intervals, whereas mortality at 1 year from admission decreased in the first and in the last time interval. Mortality at 30 days and at 1 year from discharge increased significantly in the first 2 time intervals and showed no significant change in the last (annual change, 0.22; 95% CI, 0.15 to 0.30; PϽ0.0001 for the 1986 to 1992 time interval; and 0.47; 95% CI, 0.37 to 0.57; PϽ0.001 for 2002 to 2007 for 1-year postdischarge mortality).
Multivariate logistic regression adjusting for age, sex, race, AMI site, comorbidities, complications, and invasive cardiac procedures indicated a significant decrease in in-hospital mortality per year (odds ratio [OR], 0.986; 95% CI, 0.983 to 0.988; PϽ0.0001) and a significant increase in 30-day postdischarge mortality (OR, 1.028; 95% CI, 1.024 to 1.032; PϽ0.0001) ( Table 2 ). Cox regression adjusting for the above confounders also indicated a significant increase in 1-year postdischarge mortality (hazard ratio [HR], 1.008; 95% CI, 1.006 to 1.010; PϽ0.0001).
Effect of Length of Stay
Length of stay decreased by 5.8 days, from 11.5Ϯ9.5 in 1986 to 5.7Ϯ6.7 in 2007. This could have displaced some deaths in The shorter length of stay may explain part of the increase in postdischarge mortality at 30 days but cannot account for the increase in mortality from 30 days to 1 year after discharge from 8.7% in 1986 to 10.0% in 2007 (a 1.2% increase; average annual change, 0.10%; 95% CI, 0.06 to 0.23; Figure 2 ). A small minority of patients (1.4%, nϭ4019) had length of stay longer than 30 days. Of these, 1386 died within 1 year after discharge, representing 0.5% of the patients included in the study. Excluding these deaths from the analysis did not alter the results (the increase in mortality remained 1.2%).
Cardiovascular and Noncardiovascular Mortality
Directionally different trends were observed in CVD and NCVD mortality. The trends of increasing postdischarge mortality described above for all-cause mortality were primarily for NCVD mortality (Table 1) . Thirty-day postdischarge NCVD mortality increased 5-fold, from 0.3% to 1.5% (annual change, 0.06; 95% CI, 0.05 to 0.06; R 2 ϭ0.95; PϽ0.0001). Mortality at discharge to 1 year after discharge increased more than 3-fold, from 2.1% to 7.5% (annual change, 0.22; 95% CI, 0.20 to 0.25; R 2 ϭ0.94; PϽ0.0001). On the contrary, significant changes in CVD postdischarge mortality were not observed.
Piecewise linear regression showed an increase in 30-day and 1-year postdischarge NCVD mortality in the first and second time intervals studied and no significant effects in the last time interval (online Table B ). Thirty-day and 1-year postdischarge CVD mortality did not change in the first time interval and increased in the second and decreased last time interval.
Effect of Age on Mortality Trends
The increase in NCVD postdischarge mortality was more pronounced in the older age groups. In the youngest age group, postdischarge NCVD mortality at 30 days doubled from 0.18% to 0.36% (annual change, 0.01; 95% CI, 0.00 to 0.01; R 2 ϭ0.35; Pϭ0.004; online Table C), whereas in the oldest age group, the rate increased 8-fold, from 0.39% to 3.32% (annual change, 0.13; 95% CI, 0.11 to 0.15; R 2 ϭ0.88; PϽ0.0001). Postdischarge NCVD mortality at 1 year increased from 0.84% to 1.64% (annual change, 0.04; 95% CI, 0.03 to 0.05; R 2 ϭ0.65; PϽ0.0001 in the youngest age group; and increased more than 4-fold from 3.61% to 16.23% in the oldest age group (annual change, 0.46; 95% CI, 0.40 to 0.52; R 2 ϭ0.91; PϽ0.0001).
In the youngest age group, piecewise linear regression showed a significant increase in 30-day and 1-year postdischarge NCVD mortality only in the second (1993 to 2001) time interval, whereas in the oldest age group an increase was observed in all time periods (online Table D ). In the oldest group, 1-year postdischarge CVD mortality increased significantly in all 3 time intervals (Table D of 
Effect of Type (Subendocardial Versus Transmural) of AMI on Mortality Trends
A pronounced increase in NCVD postdischarge mortality and a stable CVD postdischarge mortality were observed among patients with subendocardial infarction. In these patients, postdischarge NCVD mortality at 30 days increased more than 5-fold, from 0.35% to 1.88% (annual change, 0.07; 95% CI, 0.07 to 0.08; R 2 ϭ0.93; PϽ0.0001), and mortality at 1 year after discharge more than tripled, from 2.48% to 9.42% (annual change, 0.27; 95% CI, 0.24 to 0.31; R 2 ϭ0.92; PϽ0.0001, Table E of the online-only Data Supplement).
One-year CVD postdischarge mortality remained relatively stable in these patients. On the contrary, in patients with transmural infarction, a decrease in postdischarge CVD mortality was observed both at 30 days by 0.66% (annual change, Ϫ0.04; 95% CI, Ϫ0.05 to Ϫ0.02; R 2 ϭ0.47; Pϭ0.0004) and at 1 year by 4.89% (Ϫ0.19; 95% CI, Ϫ0.22 to Ϫ0.16; R 2 ϭ0.88; PϽ0.0001). The effects of age and type of infarction were interrelated. Younger individuals with transmural infarctions had the best long-term trends, especially for CVD mortality, whereas the opposite was true for older patients with subendocardial infarctions, especially for NCVD mortality.
Noncardiovascular Causes of Death
The most frequent causes of NCVD death were diabetes, respiratory and renal diseases, and cancer (online Table F ). As expected, the cause-specific NCVD mortality was higher in the older age groups, especially for respiratory diseases and cancer. This age-related change was more pronounced for older patients with subendocardial infarction.
A statistically significant increase in cause-specific NCVD mortality was observed in the later years of the study: for cancer (annual change, 0.06; 95% CI, 0.04 to 0.07; R 2 ϭ0.86, PϽ0.0001), for respiratory diseases (0.04; 95% CI, 0.02 to 0.05; R 2 ϭ0.78, Pϭ0.0003), for renal failure (0.03; 95% CI, 0.02 to 0.04; R 2 ϭ0.82; Pϭ0.0001), for septicemia (0.02; 95% CI, 0.02 to 0.03; R 2 ϭ0.86; Pϭ0.0001), and for Alzheimer disease (0.01; 95% CI, 0.01 to 0.01; R 2 ϭ0.84, Pϭ0.0001; online Table F ).
Sensitivity analysis (limited to patients admitted between 1994 and 2007, nϭ185 483), using logistic regression adjusting for insurance type in addition to the variables used in the primary analysis, yielded similar trends (online Table G ).
Discussion
This statewide study shows that the natural history of AMI has changed with marked decrease of in-hospital mortality but an increasing mortality after discharge. This increase in postdischarge mortality was observed primarily among the older age groups and is attributable to deaths from NCVD, especially cancer, respiratory and renal disease, and septicemia. AMI management has improved with marked lowering of in-hospital mortality. 24 This decrease is probably due to many factors including process improvement initiatives, more frequent use of pharmacological agents such as ␤-blockers, and, especially for ST-elevation-AMIs, the use of thrombolytic therapy and primary percutaneous coronary intervention. 1, 3, 4, [13] [14] [15] Also, primary prevention efforts with wider use of pharmacological therapy may have resulted in smaller AMIs with expected lower CVD mortality and postponement of some AMIs to an older age. Yeh et al 24 and others 25 also observed a reduction in case fatality in spite of treating older patients with more comorbidities. They suggested that more frequent use of guideline-based pharmacological therapy may be in part responsible for the better outcome. These investigators did not report specifically on postdischarge mortality.
The decrease in CVD mortality combined with older age and higher rates of comorbidities has resulted in higher NCVD mortality after discharge. We can speculate that the shorter length of stay in recent years may have contributed to the increase in postdischarge mortality at 30 days by displacing some deaths from the inpatient to the outpatient setting. A small portion of the increase may be due to shortening of the length of stay, with displacement of some deaths from the inpatient to the outpatient setting. However, this cannot explain the increase in mortality occurring between 30 days and 1 year after discharge. Previous investigators have presented data compatible with either no change or implying worsening of AMI mortality after discharge. For example, Roger et al 1 reported lower mortality at 30 days after discharge but no change in mortality at 1 year after discharge among 2816 AMI patients hospitalized in Minnesota from 1987 to 2006. Masoudi et al 8 observed a 25% adjusted relative risk reduction for in-hospital mortality but only a 13% adjusted relative risk reduction at 1 year, implying worsening prognosis after discharge. The higher postdischarge NCVD mortality of subendocardial AMIs, some of which were diagnosed by biomarkers only and were presumably smaller, may counterbalance the expected lower CVD mortality. 1, 2, 12 Limitations of the study include the lack of detailed clinical information may have affected the accuracy of the diagnosis of AMI and the classification of the cause of death (CVD versus NCVD). We have validated the informa- tion in MIDAS by comparing it with the hospital record in a randomly selected sample using predefined criteria for the diagnosis of AMI and found the information to be valid for this in Ͼ90% of the cases and for in-hospital death in 99% of the cases. 19 Also, other investigators have found acceptable sensitivity and positive predictive value of administrative data bases for the diagnosis of AMI. 26, 27 However, causespecific NCVD mortality rates may not be precise, and changes in coding practices may have affected the results. Coady et al 28 have reported that the death certificate overestimated CHD mortality (by approximately 20%) in the ARIC communities and that the overestimation was consistent over time. This would detract from the precision of the estimates presented in the present study. However, the bias is in a direction strengthening a conclusion of the study, for example, the increased NCVD mortality after discharge. Another limitation is that MIDAS does not include AMIs or deaths occurring outside New Jersey. Deaths occurring outside the state within 1 year of discharge accounted for approximately 1.4%, or 33 of 2351 in 2007 of the total deaths, a percentage unlikely to affect the conclusions of the study. Exclusion of non-New Jersey residents (nϭ12 381, 4.3%) did not affect the overall trends reported in this study; for example, from 1986 to 2007, 30-day mortality decreased by 8.00% (18.24% to 10.24%) when all patients are included versus 7.87% (18.32% to 10.45%) for New Jersey residents only. The respective changes at 1 year were 6.43% (26.62% to 20.19%) versus 6.36% (27.01% to 20.74%). An additional limitation, which may have affected the precision of our findings as they relate to some subsets but not the overall conclusions of the report, is that the terms "subendocardial" and "transmural" do not correspond well to the arteriographic or pathological findings, and the administrative codes are not perfectly reliable. 26, 27 However, the new definitions and diagnostic categories of AMI were not used by New Jersey hospitals during the years under consideration. 9 Steinberg et al 29 examined 165 691 admissions entered in the National Registry of Myocardial Infarction to evaluate the adoption of the 2005 classification by coders. They found little change in coding, possibly reflecting a lack of awareness of this substantial change in classification. 29 It is also possible that in the early years of the study, some recurrent AMIs were included in the analysis as first AMIs. To examine this possible limitation, we performed sensitivity analysis excluding the first 8 years (1986 to 2003) of the study, which yielded similar trends.
The inclusion of all hospitalizations for AMI in the state (other than to Veterans Affairs hospitals) strengthens the conclusions of the study and complements information from clinical trials and prospective registries, which usually include selected patients or hospitals. 30 In addition, this study includes a large number of patients, encompasses all AMIs in the state without an upper age limit, and provides long-term longitudinal follow-up for up to 22 years.
In summary, the postdischarge mortality of patients who were hospitalized for a first AMI has increased over the last 2 decades. This is due to increasing NCVD mortality, especially in the older age groups. Attention to comorbidities during hospitalization or soon after discharge and preventive and/or therapeutic strategies for diabetes, cancer, and respiratory and renal disease should become a routine part of post-AMI patient care and may result in better long-term outcomes. We cannot make firm inferences for the causes of the observed trends, based on the administrative data presented in the present study. Information from registries or controlled trials would be useful in examining the reasons for the increased NCVD mortality and in evaluating whether diagnostic, preventive, or therapeutic interventions for NCVD may further improve long-term outcomes of AMI patients.
